| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.083 | 0.6 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.075 | 0.6 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.6 |